Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-2-17
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0735-1097
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
33
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
287-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9935044-Coronary Circulation,
pubmed-meshheading:9935044-Humans,
pubmed-meshheading:9935044-Myocardial Infarction,
pubmed-meshheading:9935044-Retrospective Studies,
pubmed-meshheading:9935044-Streptokinase,
pubmed-meshheading:9935044-Thrombolytic Therapy,
pubmed-meshheading:9935044-Tissue Plasminogen Activator,
pubmed-meshheading:9935044-Treatment Outcome
|
pubmed:year |
1999
|
pubmed:articleTitle |
Better patency with SK than with tPA?
|
pubmed:publicationType |
Letter,
Comparative Study,
Comment
|